INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,062 Cr | ₹808 Cr | ₹645 Cr | ₹481 Cr | ₹518 Cr |
What is the latest Total Current Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹1,062 Cr |
| Mar2025 | ₹808 Cr |
| Mar2024 | ₹645 Cr |
| Mar2023 | ₹481 Cr |
| Mar2022 | ₹518 Cr |
How is Total Current Liabilities of INDOCO REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,062 Cr | 31.34 | |
| Mar2025 | ₹808 Cr | 25.25 | |
| Mar2024 | ₹645 Cr | 34.26 | |
| Mar2023 | ₹481 Cr | -7.21 | |
| Mar2022 | ₹518 Cr | - | |
Compare Total Current Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,923.1 Cr | -7.7% | -15.8% | -24.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -7.7% |
-15.8% |
-24.2% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses